Stay updated with breaking news from Precision Biologic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
.jpg)
For laboratories wishing to perform accurate testing for Lupus Anti-Coagulant (LA), the cryocheck™ frozen controls and reagents provide solutions to fit every stage of the pathway - screen, mix, confirm and quality control. Click to read more...
Share this article Share this article HALIFAX, NS, Jan. 11, 2021 /PRNewswire/ - Precision BioLogic Inc., a leading developer of hemostasis diagnostic products, is pleased to announce the U.S. launch of its new CRYO check Hex LA kit. Expansion to the U.S. follows successful launches in Canada, the European Union, Australia, and New Zealand. CRYOcheck Hex LA: Intended for use in clinical labs to aid in the detection of lupus anticoagulant (LA) in human plasma, Hex LA is the first commercially available hexagonal phase LA test available in a frozen format, allowing for fast and easy preparatio...
Ambrx Presents Phase 1 Trial Data Update and Phase 2/3 Clinical Trial in Progress for Lead Program ARX788 at the 2020 San Antonio Breast Cancer Symposium - 74% ORR in the Phase 1 HER2-positive Breast Cancer Trial in China and 67% ORR in the Phase 1 HER2 Expressing Pan-tumor Trial in US/AU - Multiple Global Phase 2/3 Trials to Begin Early 2021 News provided by Share this article Share this article SAN DIEGO, Dec. 10, 2020 /PRNewswire/ -- Ambrx Inc., a clinical-stage biopharmaceutical company focused on developing Precision Biologics using an expanded genetic code, provided a clinical update o...